Elevance Health revenue and financials
$400.09Change from previous close: +1.41%Absolute change: +$5.58
In the fiscal year ended December 2025, Elevance Health reported revenue of $199.13B (+12.49% year over year). Net income was $5.66B, a net margin of 2.8%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +12.49%
- 2025 vs 2024
- Net income growth
- −5.32%
- 2025 vs 2024
- Net margin
- 2.8%
- 2024: 3.4%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 4,290 | 5,808 | 8,061 | 8,399 | 8,364 | 10,688 | 6,061 | 3,827 | 4,185 | 3,270 |
| Depreciation and amortization | 1,546 | 1,393 | 1,745 | 1,675 | 1,302 | 1,154 | 1,133 | 1,132 | 111 | 104 |
| Capital expenditure | -1,116 | -1,256 | -1,296 | -1,152 | -1,087 | -1,021 | -1,077 | -1,208 | -791 | -584 |
| Investing cash flow | -1,344 | -5,167 | -5,572 | -4,560 | -9,638 | — | — | — | — | — |
| Financing cash flow | -1,738 | 1,193 | -3,349 | -1,318 | 423 | — | — | — | — | — |
| Dividends paid | -1,529 | -1,508 | -1,395 | -1,229 | -1,104 | -954 | -818 | -776 | -705 | -684 |
| Share repurchases | -2,605 | -2,900 | -2,676 | -2,316 | -1,900 | -2,700 | -1,701 | -1,685 | -1,998 | 0.0 |
| Debt issued | 6,194 | 7,985 | 2,913 | 5,671 | 5,793 | — | — | — | — | — |
| Debt repaid | -3,867 | -2,498 | -2,251 | -3,574 | — | — | — | — | — | — |
| Effect of exchange rates | -5.0 | -6.0 | -1.0 | -14.0 | -10.0 | — | — | — | — | — |
| Net change in cash | 1,203 | 1,762 | -861 | 2,507 | -861 | — | — | — | — | — |
| Free cash flow | 3,174 | 4,552 | 6,765 | 7,247 | 7,277 | — | — | — | — | — |
| Levered free cash flow | 3,400 | 7,262 | 3,005 | 8,425 | 3,614 | — | — | — | — | — |